VA
EVH icon

Vident Advisory’s Evolent Health EVH Stock Holding History

Vident Advisory’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.7K Buy
+19,588
New +$62.1K ﹤0.01% 1826
2025
Q4 		– Sell
-14,182
Closed -$120K – 1666
2025
Q3 		$120K Sell
14,182
-757
-5% -$7.35K ﹤0.01% 1593
2025
Q2 		$168K Buy
+14,939
New +$137K ﹤0.01% 1523

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vident Advisory's EVH Position: Q1 2026 in Review

Vident Advisory opened a new position in Evolent Health (EVH) in Q1 2026: 19,588 shares worth $44.7K. The stake represents ﹤0.01% of the portfolio and ranks #1826 among its holdings. This is a return to the name: Vident Advisory previously reported a position in EVH as recently as Q3 2025.

Vident Advisory first reported a position in EVH in Q2 2025 and has held it in 3 quarters since. The position peaked at $168K in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Vident Advisory held 19,588 shares of Evolent Health worth $44.7K as of Q1 2026.
  • Evolent Health was a new Vident Advisory position in Q1 2026.
  • Evolent Health made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1826 holding.
  • Vident Advisory first reported a position in Evolent Health in Q2 2025 and has held it in 3 quarters since.
  • Vident Advisory's Evolent Health position peaked at $168K in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.